Motif ID: Atf5
Z-value: 1.128
Transcription factors associated with Atf5:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Atf5 | ENSMUSG00000038539.8 | Atf5 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Atf5 | mm10_v2_chr7_-_44815658_44815682 | -0.54 | 4.6e-02 | Click! |
Top targets:
Showing 1 to 20 of 106 entries
Gene overrepresentation in biological_process category:
Showing 1 to 20 of 44 entries
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 8.7 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.2 | 7.8 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.4 | 3.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.8 | 3.3 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.2 | 2.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.4 | 1.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.3 | 1.8 | GO:0046549 | retinal cone cell development(GO:0046549) |
| 0.0 | 1.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.5 | 1.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.2 | 1.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 | 1.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 | 1.1 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.3 | 1.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.0 | 1.0 | GO:0003281 | ventricular septum development(GO:0003281) |
| 0.2 | 0.9 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.0 | 0.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.3 | 0.8 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.1 | 0.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.2 | 0.7 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 | 0.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
Gene overrepresentation in cellular_component category:
Showing 1 to 20 of 25 entries
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 8.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
| 0.7 | 7.8 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.0 | 3.6 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.2 | 3.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.1 | 1.8 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.1 | 1.4 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.0 | 1.2 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 1.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.1 | 1.0 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 0.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.0 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.0 | 0.8 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
| 0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 0.5 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 0.4 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
Gene overrepresentation in molecular_function category:
Showing 1 to 20 of 33 entries
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 8.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 1.1 | 7.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 3.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 1.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.6 | 1.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.6 | 1.8 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
| 0.1 | 1.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 1.4 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 1.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 1.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.0 | 1.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 1.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.0 | 1.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
| 0.1 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.0 | 0.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 0.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 0.7 | GO:0071532 | ornithine decarboxylase inhibitor activity(GO:0008073) ankyrin repeat binding(GO:0071532) |
| 0.1 | 0.7 | GO:0035925 | translation repressor activity, nucleic acid binding(GO:0000900) mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 0.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
